Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$5,021,152
-$356,869 QoQ
Shares Held
32,039
-9.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#263
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $75,110,921 across 10 Drug Manufacturers - General names. NVS ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
114,591 | $28,835,679 | |
| 2 | JNJ |
Johnson & Johnson
|
79,895 | $20,290,932 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
67,003 | $8,465,159 | |
| 4 | LLY |
ELI LILLY & Co
|
4,621 | $5,542,566 | |
| 5 | NVS |
Novartis AG
This page
|
32,039 | $5,021,152 | |
| 6 | MRK |
Merck & Co., Inc.
|
28,921 | $3,716,348 | |
| 7 | GSK |
GSK plc
|
23,142 | $1,213,103 | |
| 8 | PFE |
Pfizer Inc
|
40,635 | $978,490 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,021,152 | 32,039 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $5,378,021 | 35,208 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,856,470 | 35,225 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,508,917 | 35,160 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,260,761 | 35,210 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,931,045 | 62,173 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,072,240 | 62,401 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $7,169,656 | 62,334 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $6,634,054 | 62,315 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $6,027,729 | 62,315 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,300,628 | 62,401 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $6,442,542 | 63,249 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $6,388,409 | 63,308 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,803,636 | 63,083 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $5,723,796 | 63,093 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $4,828,306 | 63,522 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $5,370,528 | 63,534 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $5,577,389 | 63,560 | Shares | Other | 2022-05-04 | |
| 2021-12-31 | $5,889,091 | 67,327 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $7,404,851 | 90,546 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $8,190,158 | 89,765 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $7,587,887 | 88,768 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $8,482,363 | 89,827 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $7,028,541 | 80,825 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $7,052,617 | 80,749 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $6,510,168 | 78,959 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||